
EHT 1610
CAS No. 1425945-60-3
EHT 1610( —— )
Catalog No. M33348 CAS No. 1425945-60-3
EHT 1610 (EHT 5372) is a potent inhibitor of DYRK, with an IC50 of 0.36 nM and 0.59 nM for DYRK1A and DYRK1B, respectively.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 134 | Get Quote |
![]() ![]() |
5MG | 212 | Get Quote |
![]() ![]() |
10MG | 316 | Get Quote |
![]() ![]() |
25MG | 495 | Get Quote |
![]() ![]() |
50MG | 673 | Get Quote |
![]() ![]() |
100MG | 891 | Get Quote |
![]() ![]() |
200MG | 1197 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameEHT 1610
-
NoteResearch use only, not for human use.
-
Brief DescriptionEHT 1610 (EHT 5372) is a potent inhibitor of DYRK, with an IC50 of 0.36 nM and 0.59 nM for DYRK1A and DYRK1B, respectively.
-
DescriptionEHT 1610 is a potent inhibitor of DYRK, with IC50s of 0.36 nM (DYRK1A), 0.59 nM (DYRK1B), respectively. EHT 1610 exhibits antileukemia effect, regulates cell cycle and induces cell apoptosis-.
-
In VitroWestern Blot Analysis Cell Line:MHH-CALL-4 cells Concentration:0, 2.5, 5, 10 μM Incubation Time:4, 5 hours Result:Reduced p-cyclin D3 (Thr283), and p-FOXO1 protein level in a dose-dependent manner.
-
In VivoAnimal Model:Xenograft models of B-ALL in mice (12-14 weeks old)Dosage:20 mg/kg Administration:Intraperitoneal injection; twice a day, 5 days on, 2 days off; 3 weeks Result:Reduced leukemic burden by approximately 8% and conferred a modest survival advantage.
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetTyrosinase
-
RecptorTyrosinase | NF-κB | GSK-3 | DYRK | CDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1425945-60-3
-
Formula Weight383.4
-
Molecular FormulaC18H14FN5O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 5 mg/mL (13.04 mM; Ultrasonic )
-
SMILESCOC(=N)c1nc2ccc3ncnc(Nc4ccc(OC)cc4F)c3c2s1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chaikuad A, et al. An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases. J Med Chem. 2016 Nov 23;59(22):10315-10321.?
molnova catalog



related products
-
Methyl rosmarinate
Methyl rosmarinate is a noncompetitive tyrosinase inhibitor which is isolated from Rabdosia serra, with an IC50 of 0.28 mM for mushroom tyrosinase.Methyl rosmarinate shows antioxidative, and antifungal activities.?It has inhibitory activities against tyrosinase, α±-glucosidase, and matrix metalloproteinase-1 (MMP-1).
-
Potassium iodide
Potassium iodide is used to treat overactive thyroid and to protect the thyroid gland from the effects of radiation from inhaled or swallowed radioactive iodine.
-
lysine
Lysine is one of nine essential amino acids in humans required for growth and tissue repair, Lysine is supplied by many foods, especially red meats, fish, and dairy products.